ALS (Amyotrophic Lateral Sclerosis) is a disease that causes the death of moto neurons controlling voluntary muscles and there is no therapy.
UniGe has collaborated with the l'Università degli Studi di Milano Statale to the study of the research project for the ALS treatment, funded by AriSLA - Italian Research Foundation for Amyotrophic Lateral Sclerosis.
Thanks to the UniGe research group, under the guidance of Prof. Giambattista Bonanno, Pharmacology Professor of the Pharmacy Department, it was possible to identify the GPR17 receptor as a potential pharmacological target for the treatment of ALS.
To discover the study and learn more about the project visit the useful link.